Villard Bonnot, France

Xavier Payet-Burin

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Eveon, Other. Active years: 2019.


% Patents Active = 100.0


 

Average Co-Inventor Count = 1.3

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xavier Payet-Burin: Innovator in Pharmaceutical Composition Reconstitution

Introduction

Xavier Payet-Burin is a notable inventor based in Villard Bonnot, France. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 2 patents. His work focuses on innovative processes and devices that enhance the reconstitution of pharmaceutical products.

Latest Patents

Xavier's latest patents include a "Process for reconstitution of a solid form of a pharmaceutical composition." This invention outlines a method that involves providing a solid form of the pharmaceutical composition in a sealed container, introducing a solvent, and controlling the pressure to achieve complete reconstitution. Another significant patent is the "Device for reconstituting a pharmaceutical composition," which describes a fluidic unit designed to facilitate the reconstitution process from multiple components using a pump and a fluidic circuit.

Career Highlights

Throughout his career, Xavier has worked with various companies, including Eveon. His expertise in pharmaceutical technology has allowed him to develop innovative solutions that address complex challenges in the industry.

Collaborations

Xavier has collaborated with professionals in his field, including his coworker Arnaud Wattellier. These partnerships have contributed to the advancement of his inventions and the overall progress in pharmaceutical reconstitution technologies.

Conclusion

Xavier Payet-Burin is a distinguished inventor whose work in pharmaceutical composition reconstitution has led to valuable patents and innovations. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…